Literature DB >> 1319092

Lead nephrotoxicity and associated disorders: biochemical mechanisms.

C V Nolan1, Z A Shaikh.   

Abstract

Lead may exert toxic effects on several organ systems, but those in the kidney are the most insidious. Acute lead nephropathy is characterized by proximal tubular dysfunction with the development of a Fanconi-type syndrome, alterations in mitochondrial structure and the development of cytosolic and nuclear inclusion bodies. Intracellular lead is associated with specific high affinity proteins and can also bind to metallothionein. Chronic lead nephropathy is irreversible and is typically accompanied by interstitial fibrosis, both hyperplasia and atrophy of the tubules, glomerulonephritis and, ultimately, renal failure. In addition, lead produces renal neoplasms in experimental animals. Chronic lead exposure is also implicated in the development of saturnine gout and hypertension. The metal interacts with renal membranes and enzymes and disrupts energy production, calcium metabolism, glucose homeostasis, ion transport processes and the renin-angiotensin system. This review summarizes the biochemical effects of lead on the kidney to understand the mechanisms of lead-induced nephropathy and other associated disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319092     DOI: 10.1016/0300-483x(92)90097-x

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  17 in total

1.  Pathological structure of the kidney from adult mice with mosaic mutation.

Authors:  M Lenartowicz; M Kowal; D Buda-Lewandowska; J Styrna
Journal:  J Inherit Metab Dis       Date:  2002-12       Impact factor: 4.982

2.  Potential role of alpha-synuclein and metallothionein in lead-induced inclusion body formation.

Authors:  Peijun Zuo; Wei Qu; Ryan N Cooper; Robert A Goyer; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2009-06-19       Impact factor: 4.849

Review 3.  Pathophysiology of acute kidney injury.

Authors:  David P Basile; Melissa D Anderson; Timothy A Sutton
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

4.  The metallothionein-null phenotype is associated with heightened sensitivity to lead toxicity and an inability to form inclusion bodies.

Authors:  Wei Qu; Bhalchandra A Diwan; Jie Liu; Robert A Goyer; Tammy Dawson; John L Horton; M George Cherian; Michael P Waalkes
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

5.  Occupational exposures and chronic kidney disease: Possible associations with endotoxin and ultrafine particles.

Authors:  Todd R Sponholtz; Dale P Sandler; Christine G Parks; Katie M Applebaum
Journal:  Am J Ind Med       Date:  2015-11-17       Impact factor: 2.214

6.  Association of renal function and delta-aminolevulinic acid dehydratase polymorphism among Vietnamese and Singapore workers exposed to inorganic lead.

Authors:  S-E Chia; H J Zhou; E Yap; M T Tham; N-V Dong; N T Hong Tu; K-S Chia
Journal:  Occup Environ Med       Date:  2006-03       Impact factor: 4.402

7.  Metal toxicity and opportunistic binding of Pb(2+) in proteins.

Authors:  Michael Kirberger; Hing C Wong; Jie Jiang; Jenny J Yang
Journal:  J Inorg Biochem       Date:  2013-04-19       Impact factor: 4.155

8.  Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium.

Authors:  S R Chalkley; J Richmond; D Barltrop
Journal:  Occup Environ Med       Date:  1998-07       Impact factor: 4.402

Review 9.  Tight junction proteins and oxidative stress in heavy metals-induced nephrotoxicity.

Authors:  José L Reyes; Eduardo Molina-Jijón; Rafael Rodríguez-Muñoz; Pablo Bautista-García; Yazmin Debray-García; María Del Carmen Namorado
Journal:  Biomed Res Int       Date:  2013-04-22       Impact factor: 3.411

10.  Clinical, toxicological, biochemical, and hematologic parameters in lead exposed workers of a car battery industry.

Authors:  Sina Kianoush; Mahdi Balali-Mood; Seyed Reza Mousavi; Mohammad Taghi Shakeri; Bita Dadpour; Valiollah Moradi; Mahmoud Sadeghi
Journal:  Iran J Med Sci       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.